Menu

Heron Therapeutics, Inc. HRTX

Full chart Compare
Set alert

Price alert · HRTX

All alert types
0.36 USD -0.01 (-3.75%)

Nov 10, 2026, 12:17 PM EST

0.3401 Day range 0.414
0.26 52-week range 1.58
YTD
-72.56%
1 year
-67.86%

Revenue & Expenses

Revenue → Gross Profit: $113.56MGross Profit → Expenses: $113.56MRevenue → Cost of Revenue: $41.35MExpenses → Selling, General & Admin: $103.67MExpenses → Research & Development: $12.43MExpenses → Other Expenses: $17.66MNet Loss → Expenses: $20.20MGross Profit$113.56MNet Loss$20.20MCost of Revenue$41.35MExpenses$133.75MSelling, General & Admin$103.67MResearch & Development$12.43MOther Expenses$17.66MRevenue$154.90M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

HRTX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
154.90M144.28M127.04M107.67M86.35M
154.90M144.28M127.04M107.67M86.35M
41.35M38.65M65.11M54.87M46.02M
113.56M105.64M61.94M52.80M40.33M
116.09M117.17M172.55M227.46M259.03M
12.43M16.68M39.13M82.70M130.82M
103.67M100.48M133.42M144.75M127.33M
-2.54M-11.53M-110.61M-174.66M-218.71M
7.66M2.48M504.00K836.00K1.98M
-20.20M-13.58M-110.56M-182.02M-220.68M
-20.20M-13.58M-110.56M-182.02M-220.68M
-20.20M-13.58M-110.56M-182.02M-220.68M
-20.20M-13.58M-110.56M-182.02M-220.68M
-0.12-0.09-0.80-1.67-2.24
-0.12-0.09-0.80-1.67-2.24
-0.12-0.09-0.80-1.67-2.24
-12.54M-11.10M-110.06M-181.19M-218.71M
-12.54M-11.10M-110.06M-181.19M-218.71M
166.71M152.45M138.13M108.88M98.47M
166.71M152.45M138.13M108.88M98.47M